Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Embryonal Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Embryonal Neoplasm

Cancer Family

Embryonal Neoplasm

CI-CAN-00000013Explore in graph →

Non-malignant285 active trials7 approved drugs73 evidence items

NCIt: C3264
OncoTree: EMBT
UMLS CUI: C0027654

Overview
Statistics
Survival
Genomics22
Variants & evidence73
Drugs28
Trials1126
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (70)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 51–70 of 70 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model.
· Proc Natl Acad Sci U S A · 2012 · PMID 22550175 · validated civic_curation pubmed
Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.
· Clin Cancer Res · 2015 · PMID 26179511 · validated civic_curation pubmed
Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis.
· Sci Rep · 2016 · PMID 26786851 · validated civic_curation pubmed
Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice.
· Oncotarget · 2016 · PMID 27049722 · validated civic_curation pubmed
Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.
· Proc Natl Acad Sci U S A · 2013 · PMID 23620515 · validated civic_curation pubmed
The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects.
· Clin Cancer Res · 2016 · PMID 26733615 · validated civic_curation pubmed
Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.

Showing 51–70 of 70 publications

← Previous
1
2
3
Next →

· Oncotarget · 2016 · PMID 27286459 · validated civic_curation pubmed

Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth.

· Clin Cancer Res · 2014 · PMID 24963049 · validated civic_curation pubmed

Josephine K et al. Cancer Research 2024

· 2024 · PMID 38335254 · validated cbioportal_study pubmed

Tirode et al. Cancer Discov 2014

· 2014 · PMID 25223734 · validated cbioportal_study pubmed

Pugh et al. Nature 2012

· 2012 · PMID 22820256 · validated cbioportal_study pubmed

Northcott et al. Nature 2017

· 2017 · PMID 28726821 · validated cbioportal_study pubmed

Jones et al. Nature 2012

· 2012 · PMID 22832583 · validated cbioportal_study pubmed

Robinson et al. Nature 2012

· 2012 · PMID 22722829 · validated cbioportal_study pubmed

Morrissy et al. Nature 2016

· 2016 · PMID 26760213 · validated cbioportal_study pubmed

E. Chun et al. Cancer Cell 2016

· 2016 · PMID 26977886 · validated cbioportal_study pubmed

Molenaar et al. Nature 2012

· 2012 · PMID 22367537 · validated cbioportal_study pubmed

Pugh et al. Nat Genet 2013

· 2013 · PMID 23334666 · validated cbioportal_study pubmed

Gunes et al. Nat Genet 2023

· 2023 · PMID 37169874 · validated cbioportal_study pubmed

Peifer et al. Nature 2015

· 2015 · PMID 26466568 · validated cbioportal_study pubmed